News

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...
A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...
While the makers of Ozempic have stated that their GLP-1 medication was not made to be used as a weight loss drug, nor should ...
Some new medications in development are also trying to solve for a persistent side effect of existing drugs: Patients who ...
Wegovy can help people with excess weight and obesity lose weight and improve their health. And you don’t need to drive to a ...
A trial pitting weight loss jab Mounjaro against competitor Wegovy ended with one clear winner, and Mounjaro is getting ...
GLP-1 drugs like Ozempic and Wegovy change food cravings and taste preferences—leading to weight loss beyond just reduced appetite.
Previous clinical studies suggested that - when combined with changes to their diet, exercise and behavioural support - Wegovy users could lose more than 10% of their body weight after a year on the ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions in body weight and waist circumference.
A federal judge on Wednesday ruled that the Food and Drug Administration’s (FDA) decision to remove popular GLP-1s from its drug shortage list, ending the sale of compounded versions of the ...
Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.
Novo Nordisk’s drugs are being linked to an eye condition that can cause vision loss, while health tech companies made CNBC’s ...